Protein L is known as a “superantigen” because it can bind antibodies in unusual ways
The company has improved access to quality healthcare for seniors across both urban and rural areas
Inclacumab was generally well tolerated in THRIVE-131
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
The performance was below anticipated levels, primarily due to external factors such as seasonal disruption that affected overall results
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
Our specialty chemical businesses have continued to perform strongly, growing double digit YoY
Subscribe To Our Newsletter & Stay Updated